← All Ani Pharmaceuticals INC filings

Ani Pharmaceuticals INC Form 4 insider transactions

NASDAQ
ANIP
Ani Pharmaceuticals INC
Form 4: ANI Pharmaceuticals CEO Nikhil Lalwani Disposes of Shares for Tax Obligations
Nikhil Lalwani, President & CEO of ANI Pharmaceuticals, disposed of 10,014 shares of common stock to cover tax obligations related to vesting restricted stock.
NASDAQ
ANIP
Ani Pharmaceuticals INC
Form 4: ANI Pharmaceuticals Executive Gutwerg Sells Shares for Tax Obligations
Ori Gutwerg, SVP of Generics at ANI Pharmaceuticals, disposed of shares to cover tax obligations related to the vesting of restricted stock.
NASDAQ
ANIP
Ani Pharmaceuticals INC
Form 4: ANI Pharmaceuticals Executive Chad Gassert Reports Stock Transactions
Chad Gassert, SVP at ANI Pharmaceuticals, reports disposition of shares for tax purposes following vesting of restricted stock.
NASDAQ
ANIP
Ani Pharmaceuticals INC
Form 4: ANI Pharmaceuticals SVP, Chief HR Officer Reports Stock Transaction
Krista Davis, SVP, Chief HR Officer of ANI Pharmaceuticals, reports the disposition of 1,173 shares of common stock to cover tax obligations related to vesting restricted stock.
NASDAQ
ANIP
Ani Pharmaceuticals INC
Form 4: ANI Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
Meredith Cook, SR. VP, GENERAL COUNSEL & SEC. of ANI Pharmaceuticals, sold shares to cover tax obligations related to vesting restricted stock.
NASDAQ
ANIP
Ani Pharmaceuticals INC
Form 4: ANI Pharmaceuticals SVP & CFO Stephen P. Carey Reports Stock Transaction
Stephen P. Carey, SVP & CFO of ANI Pharmaceuticals, reported a transaction involving the withholding of shares for tax purposes related to the vesting of restricted stock.